Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advanced Corneal Crosslinking-II for Keratoconus
NCT02514200Phase 2Unknown
- Sponsor
- Umeå University
- Start
- Mar 2014
- Primary completion
- Oct 2019
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Umeå University. Primary endpoint: Change from baseline in refraction at 12 months. Status: unknown.
Beyond the preview
Go deeper on NCT02514200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02514200.